Clinical Trial Update: Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating purified CD34+ stem cells from umbilical cord blood for chronic ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Ischemia
• Cerebral Infarction
• Middle Cerebral Artery Infarction
• Stroke

Drugs mentioned

• Purified Umbilical Cord Blood CD34+ Stem Cells (CD34+ hematopoietic stem cells)

Snippet

Sponsor: China Medical University Hospital | Conditions: Ischemic Stroke, Ischaemic Cerebral Infarction | Phase 1 | Status: UNKNOWN